Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANO1 is a calcium-activated chloride channel (CaCC) involved in a wide array of physiological processes including transepithelial anion transport, smooth muscle contraction, and pacemaking activity in the gastrointestinal tract. It functions as a dimer, with each subunit containing ten transmembrane domains. ANO1's role in various diseases, particularly cancer, makes it an emerging drug target, although challenges remain regarding selectivity and potential off-target effects.
Pharmacological antagonism (channel blockade)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride Channel Protein Anoctamin 1 (ANO1).